DWOCX
Price
$15.19
Change
-$0.07 (-0.46%)
Updated
Sep 20 closing price
GAFFX
Price
$77.04
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

DWOCX vs GAFFX

Header iconDWOCX vs GAFFX Comparison
Open Charts DWOCX vs GAFFXBanner chart's image
BNY Mellon Research Growth C
Price$15.19
Change-$0.07 (-0.46%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer F3
Price$77.04
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DWOCX vs GAFFX Comparison Chart
Loading...
VS
DWOCX vs. GAFFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DWOCX is a StrongBuy and GAFFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 290B vs. DWOCX (1.64B). GAFFX pays higher dividends than DWOCX: GAFFX (0.75) vs DWOCX (0.00). DWOCX was incepted earlier than GAFFX: DWOCX (16 years) vs GAFFX (8 years). GAFFX (31.00) and DWOCX (30.98) have comparable annual turnover. DWOCX has a lower initial minimum investment than GAFFX: DWOCX (1000) vs GAFFX (1000000). DWOCX (31.52) and GAFFX (30.65) have marching annual gain over last year. GAFFX return over 5 years is better than : 55.06 vs. DWOCX (12.60).
DWOCXGAFFXDWOCX / GAFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years8 years-
Gain YTD16.84621.99577%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B290B1%
Annual Yield % from dividends0.000.75-
Returns for 1 year31.5230.65103%
Returns for 3 years-18.331.28-1,436%
Returns for 5 years12.6055.0623%
Returns for 10 years12.27N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRT9.790.49
+5.27%
Cross Timbers Royalty Trust
VKTX70.542.38
+3.49%
Viking Therapeutics
ORCL168.000.41
+0.24%
Oracle Corp
LRMR7.07-0.07
-0.98%
Larimar Therapeutics
KAR16.63-0.29
-1.71%
OPENLANE